“There is much more hope.” These words from a 9+ year stage IV NSCLC survivor resonate deeply. Her journey, marked by multiple recurrences and triumphs, showcases the remarkable advancements in lung cancer treatment and the power of personalized medicine
Thriving 9½ Years with Recurrences – “Winning” with New Treatments Read More »
A Stage IV non-small cell lung cancer diagnosis at age 42 surprised Anne P., a never-smoker and mother of two. Thanks to comprehensive genomic tumor testing, she now uses targeted therapy for her EGFR- and T790M-positive lung tumors, maintaining an active life and raising awareness about lung cancer research.
“Incurable” Advanced NSCLC to Active Lifestyle Read More »
Genomic testing unlocked a miracle for this survivor, transforming Amy Grove’s difficult Stage IV diagnosis into a stable and hopeful future.
Life-Saving Biomarker Test – MET Amplification “Miracle” Read More »
When a chance CAT scan revealed stage IV non-small cell lung cancer that had already spread to his adrenal gland, Bob C. faced daunting odds. Yet an innovative immunotherapy trial brought new hope, minimal side effects, and precious extra years of life.
A Clinical Trial and Unyielding Spirit Turned a Dire Diagnosis into an Ongoing Triumph Read More »
When non-small cell lung cancer (NSCLC) progresses to Stage IV, it means the tumor has spread beyond the lung to distant organs such as the brain, liver, bones, or adrenal glands. This advanced stage can be daunting for patients and caregivers alike, but the good news is that treatment approaches have evolved considerably over the
Latest Treatment Strategies for Advanced NSCLC Read More »
